Bangladesh greenlights gene editing to ‘meet the needs of farmers and consumers’

screenshot am
Scientists at Bangladesh Rice Research Institute developing the country’s first-generation gene-edited rice lines Credit: BRRI
The Agriculture & Food Systems Institute (AFSI), under the auspices of the South Asia Biosafety Program (SABP) and in collaboration with the Bangladesh Agricultural Research Council (BARC), Bangladesh Academy of Sciences (BAS), and Biotech Consortium India Limited (BCIL), organized two events in February 2024 to raise awareness about the publication of “Standard Operating Procedures (SOP) for Research and Release of Genome Edited Plants of Categories SDN-1 and SDN-2, 2023” by the Ministry of Agriculture (MoA). The culmination of a multi-year drafting process involving a broad range of stakeholders, the SOP details the procedure whereby applicants can demonstrate the absence of any exogenously introduced DNA and request confirmation through the appropriate channels to register or release the plant following the same procedure as those used for conventionally bred counterparts.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

ac a fbd c a af b

Raising awareness

At the request of BAS and BARC, AFSI started collaborating with stakeholders in Bangladesh on outreach activities to raise awareness about genome editing, beginning with the webinar “Genome Editing in Agriculture: Potential Opportunities and Way Forward in Bangladesh” on October 4, 2021. Follow-up activities included a variety of webinars and training events, as well as the in-person “Conference on Genome Editing in Plants: Harnessing the Benefits for Bangladesh” a year later.

Watch the Webinar»

a d f e c ab c eProviding expertise

On July 19, 2022, the BAS Council constituted the Expert Committee on Gene Edited Plants in Bangladesh and invited SABP Country Coordinator Prof. Dr. Rakha Hari Sarker, SABP Senior Advisor Dr. Vibha Ahuja, and AFSI Fellow Prof. Dr. Aparna Islam to serve as members. Upon invitation by the Secretary of the Ministry of Agriculture, the committee proposed a mechanism to allow genome edited plants to move through research and development and have a path toward commercialization. Following stakeholder consultations and discussions throughout 2022 and 2023, the committee drafted an SOP for this purpose.

fb bde f f ef bc ebConducting outreach

The Ministry of Agriculture officially published the SOP in December 2023. The “Conference on Genome Editing for Agriculture in Bangladesh” on February 11, 2024 was organized to inform a wider audience about this new resource, as well as how genome editing technology can support agriculture in Bangladesh. Aimed at a more technical group, the “Workshop on Standard Operating Procedures for Research and Release of Genome Edited Plants in Bangladesh” on February 13, 2024 focused on the SOP and techniques used to demonstrate the absence of the transgene(s).

About the Conference»

[Editor’s note: Download the PDF here]

Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Picture1
The FDA couldn’t find a vaccine safety crisis, so it buried its own research
Screenshot-2026-04-22-at-12.21.32-PM
Viewpoint: Why the retracted Monsanto glyphosate study doesn’t change the science—the world’s most popular herbicide is safe 
ChatGPT-Image-May-7-2026-12_32_36-PM
Viewpoint: The state of U.S. vaccine policy? Dismal nationally, but some states are stepping up.
placebo
Viewpoint — Alternative medicine and the placebo effect: Selling a reassuring illusion of health
_20250221_nib_rfk_trump
Viewpoint: 'Crisis of public trust': Autism support community shocked RFK continues to peddle false claims about the danger of vaccines
ChatGPT-Image-May-18-2026-01_45_05-PM-2
Newest hantavirus conspiracy: Online disinformation turns outbreak into latest ivermectin grift
Screenshot-2026-04-13-at-1.39.26-PM
Viewpoint: ‘Safer for children?’ Stonyfield yogurt under fire for deceptive organic marketing
Screenshot-2026-04-22-at-10.46.29-AM
Viewpoint: How to counter science disinformation? Science journalist offers 12 practical tips
the magic of mRNA
Viewpoint: Anti-vax fake ‘turbo cancer’ claims threaten cancer treatment breakthroughs
ChatGPT-Image-May-7-2026-12_16_37-PM-2
Viewpoint: Are cancer rates ‘skyrocketing’ as RFK, Jr. and MAHA claim? The evidence says mostly the opposite
artificial intelligence brain think illustration md
Viewpoint — Digital gods and human extinction: Will we be the first species ever to design our own descendants?
Defense_Secretary_Ash_Carter_tours_the_Microsoft_Cybercrime_Center_in_Seattle_March_3_2016
How criminals are using AI to target social media users and steal their money and confidential data
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.